Related Experiment Video
Updated: May 3, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Targeting the epigenetic machinery of cancer cells
M F Montenegro1, L Sánchez-del-Campo2, M P Fernández-Pérez1
1Department of Biochemistry and Molecular Biology A, University of Murcia, Murcia, Spain.
Abstract:
Cancer is characterized by uncontrolled cell growth and the acquisition of metastatic properties. In most cases, the activation of oncogenes and/or deactivation of tumour suppressor genes lead to uncontrolled cell cycle progression and inactivation of apoptotic mechanisms. Although the underlying mechanisms of carcinogenesis remain unknown, increasing evidence links aberrant regulation of methylation to tumourigenesis. In addition to the methylation of DNA and histones, methylation of nonhistone proteins, such as transcription factors, is also implicated in the biology and development of cancer. Because the metabolic cycling of methionine is a key pathway for many of these methylating reactions, strategies to target the epigenetic machinery of cancer cells could result in novel and efficient anticancer therapies. The application of these new epigenetic therapies could be of utility in the promotion of E2F1-dependent apoptosis in cancer cells, in avoiding metastatic pathways and/or in sensitizing tumour cells to radiotherapy.
Insights
Targeting epigenetic alterations in cancer, including aberrant methylation, offers novel therapeutic strategies. Manipulating methionine metabolism could enhance anticancer therapies by promoting apoptosis and reducing metastasis.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Cancer involves uncontrolled cell growth and metastasis, often due to oncogene activation or tumor suppressor gene inactivation.
- Aberrant regulation of methylation, including DNA, histones, and nonhistone proteins, is increasingly linked to tumorigenesis.
- Methionine metabolism is crucial for many methylation reactions involved in cancer development.
Purpose of the Study:
- To explore the potential of targeting epigenetic machinery in cancer cells for novel anticancer therapies.
- To investigate the role of aberrant methylation in cancer biology and development.
- To highlight the therapeutic utility of epigenetic modifications in cancer treatment.
Main Methods:
- Reviewing evidence linking aberrant methylation patterns to cancer.
- Analyzing the role of methionine metabolism in cellular methylation processes.
- Evaluating the potential of epigenetic therapies for cancer treatment.
Main Results:
- Aberrant methylation of DNA, histones, and nonhistone proteins is implicated in cancer.
- Methionine metabolic cycling is a key pathway for methylation reactions in cancer cells.
- Targeting epigenetic machinery offers potential for novel anticancer therapies.
Conclusions:
- Strategies targeting epigenetic machinery, particularly methylation, hold promise for effective cancer therapies.
- Epigenetic therapies could promote cancer cell apoptosis (programmed cell death) via E2F1.
- These therapies may also help prevent cancer metastasis and sensitize tumors to radiotherapy.
More Related Videos
09:56Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins
Published on: October 31, 2025
10:41An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Mitogens and the Cell Cycle
Treatment Resistant Cancers